Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.
about
FXR agonists as therapeutic agents for non-alcoholic fatty liver disease.Quercetin induces the selective uptake of HDL-cholesterol via promoting SR-BI expression and the activation of the PPARγ/LXRα pathway.Low-density lipoprotein (LDL)-dependent uptake of Gram-positive lipoteichoic acid and Gram-negative lipopolysaccharide occurs through LDL receptor.
P2860
Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.
@ast
Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.
@en
type
label
Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.
@ast
Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.
@en
prefLabel
Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.
@ast
Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.
@en
P2860
P1433
P1476
Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.
@en
P2093
Karin Eigner
Stefanie Fruhwürth
P2860
P304
P356
10.1371/JOURNAL.PONE.0102026
P407
P577
2014-07-10T00:00:00Z